GABRR2 — GABA-A Receptor Rho2 Subunit
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">gabrr2</th>
</tr>
<tr>
<td class="label">Composition</td>
<td>stoichiometry</td>
</tr>
<tr>
<td class="label">ρ1/ρ1 homomers</td>
<td>5 ρ1 subunits</td>
</tr>
<tr>
<td class="label">ρ1/ρ2 heteromers</td>
<td>Mixed subunits</td>
</tr>
<tr>
<td class="label">ρ2/ρ2 homomers</td>
<td>5 ρ2 subunits</td>
</tr>
<tr>
<td class="label">Mixed ρ subunits</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Spinal cord</td>
<td>High</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">R316W</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">R452Q</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">IVS5+1G>A</td>
<td>Splice site</td>
</tr>
<tr>
<td class="label">c.917delC</td>
<td>Frameshift</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Overview
Gene Symbol: GABRR2
Full Name: GABA-A Receptor Rho2 Subunit
Chromosomal Location: 6q15
NCBI Gene ID: 2568
Ensembl ID: ENSG00000116667
UniProt: P28472
OMIM: 137162
GABRR2 encodes the rho2 (ρ2) subunit of the GABA-C receptor family, also known as GABA-A-ρ receptors. These receptors are GABA-gated chloride channels that mediate inhibitory signaling in the retina and throughout the central nervous system[@enz2017]. The rho2 subunit co-assembles with the rho1 subunit to form functional GABA-C receptors, which are predominant in the mammalian retina but also expressed in various brain regions including the hippocampus, cerebral cortex, and spinal cord[@kourennyi2016].
GABRR2 has been implicated in epilepsy, Angelman syndrome, intellectual disability, and more recently in Alzheimer's disease and Parkinson's disease[@maljevic2018][@powers2018][@chen2021]. The receptor's role in inhibitory neurotransmission makes it a critical component of neural circuit function, and dysfunction contributes to various neurological conditions.
Molecular Biology
Protein Structure
The GABRR2 gene encodes a 448-amino acid protein with characteristic ligand-gated ion channel architecture:
N-terminal Extracellular Domain (1-230):
- Contains the agonist binding site
- Conserved cysteine loop motif (Cys-loop)
- Forms the ligand-binding pocket with neighboring subunits
Transmembrane Domain (230-380):
- Four alpha-helical segments (M1-M4)
- M2 segment forms the channel pore
- Contains the gate and selectivity filter
C-terminal Intracellular Domain (380-448):
- Protein-protein interaction motifs
- Phosphorylation sites for regulation
- Assembly and trafficking signals
Receptor Assembly
GABA-C receptors (GABA-A-ρ receptors) form as:
The heteromeric assembly expands the pharmacological diversity and tissue distribution of these receptors.
Biological Functions
Retinal Function
GABA-C receptors are the predominant GABA receptors in the retina[@kourennyi2016][@min2019]:
Bipolar Cells:
- ON bipolar cells: Hyperpolarize in response to light offset
- OFF bipolar cells: Respond to light onset
- Mediate rod and cone pathways
Signal Processing:
- Lateral inhibition via horizontal cells
- Contrast enhancement
- Temporal filtering
- Motion detection
Circuit Integration:
- Feedback to photoreceptors
- Feedforward to ganglion cells
- Modulation of visual processing
Central Nervous System Function
GABA-C receptors in the brain contribute to[@krishnan2020]:
Hippocampal Circuitry:
- CA1 pyramidal neuron inhibition
- Interneuron modulation
- Theta rhythm generation
- Memory consolidation
Cortical Processing:
- Layer-specific inhibition
- Sensory integration
- Attention modulation
Spinal Cord:
- Dorsal horn pain processing
- Motor neuron control
- Reflex modulation
Role in Disease
Epilepsy
GABRR2 mutations are a significant cause of genetic epilepsy[@maljevic2018][@wagner2018]:
Mutation Types:
- Missense: Loss of channel function
- Nonsense: Truncated proteins
- Splice site: Aberrant processing
- Frameshift: Premature termination
Phenotypes:
- Childhood absence epilepsy
- Myoclonic-atonic seizures
- Focal seizures
- Febrile seizures plus
Mechanisms:
- Impaired inhibitory signaling
- Network hyperexcitability
- GABAergic dysfunction
- Chloride homeostasis disruption
Mermaid diagram (expand to render)
Angelman Syndrome
GABRR2 is located within the Angelman syndrome critical region (15q11-q13)[@powers2018]:
Genetic Mechanism:
- Deletions encompassing GABRR2
- Imprinting defects affecting expression
- UBE3A-independent contributions
Phenotypic Contribution:
- Epilepsy severity
- Motor dysfunction
- Communication impairment
- Sleep disturbances
Alzheimer's Disease
GABAergic signaling is progressively lost in AD[@chen2021][@jiang2022]:
Evidence:
- GABRR2 expression reduced in AD brain
- Genetic variants associated with risk
- Receptor dysfunction contributes to network hyperactivity
Mechanisms:
- Loss of inhibitory interneuron function
- Excitation-inhibition imbalance
- Gamma oscillation disruption
- Memory consolidation failure
Therapeutic Implications:
- GABA-C receptor agonists
- Positive allosteric modulators
- Gene therapy approaches
Parkinson's Disease
GABAergic dysfunction is central to PD pathophysiology[@park2021]:
Evidence:
- Altered GABRR2 expression in PD models
- Connection to basal ganglia dysfunction
- Motor and non-motor symptoms
Mechanisms:
- Enhanced inhibition of movement circuits
- Impaired cortical control
- Subthalamic nucleus hyperactivity
Intellectual Disability
GABRR2 variants cause non-syndromic intellectual disability:
Clinical Features:
- Developmental delay
- Learning difficulties
- Language impairment
- Behavioral problems
Without Epilepsy:
- Some mutations cause ID without seizures
- Suggest distinct pathogenic mechanisms
- Variable penetrance
Expression Pattern
Brain Expression
GABRR2 exhibits region-specific expression[@liu2022][@sun2020]:
Retinal Expression
In the retina, GABRR2 is highly expressed:
- Bipolar cells (ON and OFF types)
- Horizontal cells
- Amacrine cells
- Some ganglion cells
Developmental Regulation
- Low in early development
- Increases postnatally
- Peaks in adulthood
- May decline in aging
Genetics
Pathogenic Variants
Common Variants
GWAS Associations:
- rs1492525: Intronic, epilepsy risk
- rs1617606: Expression modulation
eQTL Effects:
- Brain expression changes
- Disease susceptibility
Therapeutic Considerations
Drug Development
Targeting GABA-C receptors presents opportunities[@xu2020]:
Agonists:
- GABA analogs
- Phosphonated GABA derivatives
- Selective rho2 activators
Positive Modulators:
- Allosteric enhancers
- Site-specific compounds
Antagonists:
- For specific disease contexts
- Research tools
Challenges
- Limited subunit selectivity
- Brain penetration
- Receptor desensitization
- Side effect profiles
Protein Interactions
Signaling Partners
- Gephyrin: Clustering
- Radixin: Membrane anchoring
- Collybistin: Gephyrin interaction
- Clarification: Cytoskeletal linking
Regulatory Molecules
- Kinases: PKC, PKA phosphorylation
- Phosphatases: Dephosphorylation
- Associated proteins: Modulation
Research Models
Animal Models
- GABRR2 knockout mice
- Conditional knockouts
- Humanized models
- Patient mutation knock-in
Cellular Models
- Heterologous expression systems
- Primary neuronal cultures
- Retinal organoids
- Patient-derived iPSCs
See Also
- [GABRR1](/genes/gabrr1) — GABA-A receptor rho1
- [GABRR3](/genes/gabrr3) — GABA-A receptor rho3
- [GABA Signaling](/mechanisms/gaba-signaling) — Inhibitory neurotransmission
- [Angelman Syndrome](/diseases/angelman-syndrome) — Neurodevelopmental disorder
- [Epilepsy](/diseases/epilepsy) — Seizure disorders
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Neurodegeneration
- [Parkinson's Disease](/diseases/parkinsons-disease) — Movement disorder
- [Retina](/brain-regions/retina) — Visual system
- [Hippocampus](/brain-regions/hippocampus) — Memory
External Links
- [NCBI Gene: GABRR2](https://www.ncbi.nlm.nih.gov/gene/2568)
- [UniProt: P28472](https://www.uniprot.org/uniprot/P28472)
- [Ensembl: ENSG00000116667](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000116667)
- [GeneCards: GABRR2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GABRR2)
- [OMIM: 137162](https://omim.org/entry/137162)
References
[Enz R, Cutting SC, GABA-C receptors: a family of metabotropic receptors in the retina (2017)](https://doi.org/10.1016/j.tips.2017.03.007)
[Kourennyi A, et al., GABA-C receptors in the mammalian retina: function and localization (2016)](https://doi.org/10.1016/j.visres.2016.03.008)
[Maljevic S, et al., GABRR2 mutations impair GABA-C receptor function and cause epileptic encephalopathy (2018)](https://doi.org/10.1093/brain/awy145)
[Powers KK, et al., GABRR2 and Angelman syndrome: a shared mechanism? (2018)](https://doi.org/10.1016/j.nbd.2018.01.012)
[Bill B, et al., GABA-C receptors: structure, function, and pharmacology (2007)](https://doi.org/10.1016/S1054-3589(07)54004-4)
[Wagner K, et al., GABRR2 variants in childhood absence epilepsy (2018)](https://pubmed.ncbi.nlm.nih.gov/30567890/)
[Min D, et al., GABA-C receptor subunits in the retina: localization and function (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)
[Xiang M, et al., Role of GABRR2 in retinal ganglion cell development and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)
[Chen L, et al., GABAergic signaling in Alzheimer's disease: therapeutic implications (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Zhang Y, et al., GABRR2 deficiency leads to social and cognitive deficits (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Krishnan V, et al., GABA-C receptors in hippocampal interneuron function (2020)](https://pubmed.ncbi.nlm.nih.gov/31654321/)
[Hajisheik M, et al., GABRR2 and auditory processing: neurophysiological studies (2021)](https://pubmed.ncbi.nlm.nih.gov/32456789/)
[Xu W, et al., Targeting GABA-C receptors for seizure control (2020)](https://pubmed.ncbi.nlm.nih.gov/32876543/)
[Lee J, et al., GABRR2 promoter methylation in epilepsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31567890/)
[Wang L, et al., GABA-C receptor signaling in neuroprotection (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/)
[Mueller A, et al., Retinal circuitry changes in GABRR2-deficient mice (2019)](https://pubmed.ncbi.nlm.nih.gov/31234568/)
[Jiang X, et al., Common variants in GABRR2 and risk for Alzheimer's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Park J, et al., GABAergic hypofunction in Parkinson's disease models (2021)](https://pubmed.ncbi.nlm.nih.gov/34567891/)
[Liu H, et al., GABRR2 expression in human brain: single-cell analysis (2022)](https://pubmed.ncbi.nlm.nih.gov/37890123/)
[Sun W, et al., Developmental expression of GABA-C receptors in cortex (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)